{"product_id":"uw-medicine-2nd-international-symposium-on-merkel","title":"UW Medicine 2nd International Symposium on Merkel Cell Carcinoma 2022","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eUW Medicine 2nd International Symposium on Merkel Cell Carcinoma 2022\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003eInclude: 30 videos + 39 pdfs, size: 9.21 GB \u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eDate \u0026amp; Location\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eMonday, April 25, 2022, 7:00 AM – Tuesday, April 26, 2022, 4:00 PM, Graduate Hotel, Seattle, WA\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003eIt  is designed to explore emerging data that may allow improvements in understand the basic biology that drives this disease, clinical guidelines, and to develop innovative approaches. Updates from the most recent clinical guidelines as well as emerging data regarding MCC biology are highlighted in plenary sessions. The educational purpose of this symposium is to disseminate emerging data and to advance MCC research through a stimulating and collaborative meeting.\u003cbr\u003e\u003cbr\u003eThe need for clinicians to continuously stay abreast of developments and current standards of care in the field of MCC is challenging because it is so rapidly evolving. Many clinicians are not familiar with how MCC differs from other skin cancers in its optimal management.\u003cbr\u003e\u003cbr\u003eThis activity will offer comprehensive reviews of the established standards of care and recent clinical advances in the field of MCC management, national cancer guidelines, and treatment recommendations in various clinical settings.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eUpon completion of this activity, attendees should be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eAddress the outstanding questions in MCC basic biology and how they can lead to improvements in clinical care.\u003c\/li\u003e\n\u003cli\u003eIdentify the current clinical MCC biomarkers of disease burden and how to interpret those.\u003c\/li\u003e\n\u003cli\u003eReview and discuss the updated national MCC clinical guidelines.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cstrong\u003eWHO SHOULD ATTEND\u003c\/strong\u003e\u003cbr\u003eHealthcare providers including MDs, DOs, PhDs, other healthcare professionals, and scientists interested in MCC.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e‘Immunotherapy for solid organ transplant recipients with advanced MCC and other skin cancers.mp4\u003c\/li\u003e\n\u003cli\u003e‘Immunotherapy for solid organ transplant recipients with advanced MCC and other skin cancers.pdf\u003c\/li\u003e\n\u003cli\u003eAblative Radiation Therapy for Merkel Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eAblative Radiation Therapy for Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eAbstract- Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy.mp4\u003c\/li\u003e\n\u003cli\u003eAbstract- Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy.pdf\u003c\/li\u003e\n\u003cli\u003eAbstract- Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy.mp4\u003c\/li\u003e\n\u003cli\u003eAbstract- Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy.pdf\u003c\/li\u003e\n\u003cli\u003eAbstract- MCPyV ALTO is silenced in -virus-positive Merkel cell carcinoma and suppresses tumorigenesis.pdf\u003c\/li\u003e\n\u003cli\u003eAbstract- Merkel polyoma virus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eAbstract- Merkel polyoma virus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eAbstract- Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1 PD-1- refractory Merkel 1 Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eAbstract- Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1 PD-1- refractory Merkel 1 Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eAbstract- The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do..mp4\u003c\/li\u003e\n\u003cli\u003eAbstract- The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do..pdf\u003c\/li\u003e\n\u003cli\u003eAnimal Models of MCC.mp4\u003c\/li\u003e\n\u003cli\u003eAnimal Models of MCC.pdf\u003c\/li\u003e\n\u003cli\u003eAST-008 and TLR9 agonists in Merkel cell carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eAST-008 and TLR9 agonists in Merkel cell carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eAvelumab in mMMC- real-world data.mp4\u003c\/li\u003e\n\u003cli\u003eAvelumab in mMMC- real-world data.pdf\u003c\/li\u003e\n\u003cli\u003eCan we harness T-cells specific for Merkel cell polyomavirus with therapuetic vaccination..mp4\u003c\/li\u003e\n\u003cli\u003eCan we harness T-cells specific for Merkel cell polyomavirus with therapuetic vaccination..pdf\u003c\/li\u003e\n\u003cli\u003eClues to the Origins of Merkel Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eClues to the Origins of Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eContribution of Merkel Cell Polyomavirus to Merkel Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eContribution of Merkel Cell Polyomavirus to Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eCross-sectional Imaging In Merkel Cell Carcinoma- Is Less More..mp4\u003c\/li\u003e\n\u003cli\u003eCross-sectional Imaging In Merkel Cell Carcinoma- Is Less More..pdf\u003c\/li\u003e\n\u003cli\u003eDiagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eDiagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eEpigenetic and Genetic Determinants of Merkel Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eEpigenetic and Genetic Determinants of Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eFeatured Abstract- Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation.mp4\u003c\/li\u003e\n\u003cli\u003eFeatured Abstract- Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation.pdf\u003c\/li\u003e\n\u003cli\u003eImmunotherapy Platform and Related-omics.mp4\u003c\/li\u003e\n\u003cli\u003eImmunotherapy Platform and Related-omics.pdf\u003c\/li\u003e\n\u003cli\u003eMCC Immunotherapy- Lessons Learnt and Unmet Needs.mp4\u003c\/li\u003e\n\u003cli\u003eMCC Immunotherapy- Lessons Learnt and Unmet Needs.pdf\u003c\/li\u003e\n\u003cli\u003eMCPyV-specific T cell discovery for adoptive T cell therapy.mp4\u003c\/li\u003e\n\u003cli\u003eMCPyV-specific T cell discovery for adoptive T cell therapy.pdf\u003c\/li\u003e\n\u003cli\u003eMechanisms of Oncogenesis- MCC Cell of Origin.mp4\u003c\/li\u003e\n\u003cli\u003eMechanisms of Oncogenesis- MCC Cell of Origin.pdf\u003c\/li\u003e\n\u003cli\u003eMerkel Cell Carcinoma in France- Characteristics of a Cohort of 1300 Patients.mp4\u003c\/li\u003e\n\u003cli\u003eMerkel Cell Carcinoma in France- Characteristics of a Cohort of 1300 Patients.pdf\u003c\/li\u003e\n\u003cli\u003eMJ2207 CME Questions Monday with ANSWERS.pdf\u003c\/li\u003e\n\u003cli\u003eMJ2207 CME Questions Monday.pdf\u003c\/li\u003e\n\u003cli\u003eMJ2207 CME Questions Tuesday with ANSWERS.pdf\u003c\/li\u003e\n\u003cli\u003eMJ2207 CME Questions Tuesday.pdf\u003c\/li\u003e\n\u003cli\u003eNeoadjuvant PD-1 Pathway Blockade for MCC- a window into treatment response and primary resistance.mp4\u003c\/li\u003e\n\u003cli\u003eNeoadjuvant PD-1 Pathway Blockade for MCC- a window into treatment response and primary resistance.pdf\u003c\/li\u003e\n\u003cli\u003eQ\u0026amp;A Summary.pdf\u003c\/li\u003e\n\u003cli\u003eRandomized Phase II Study of NIVO + IPI vs. NIVO + IPI + SBRT in Metastatic or Recurrent Merkel Cell Carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eRandomized Phase II Study of NIVO + IPI vs. NIVO + IPI + SBRT in Metastatic or Recurrent Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eReal world management of MCC patients in France.mp4\u003c\/li\u003e\n\u003cli\u003eReal world management of MCC patients in France.pdf\u003c\/li\u003e\n\u003cli\u003eRegistration \u0026amp; Breakfast.pdf\u003c\/li\u003e\n\u003cli\u003eRole of radiotherapy in Merkel cell cancer.mp4\u003c\/li\u003e\n\u003cli\u003eRole of radiotherapy in Merkel cell cancer.pdf\u003c\/li\u003e\n\u003cli\u003eState of the Field- Merkel Cell Carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eSurgery – Adjuvant RT.mp4\u003c\/li\u003e\n\u003cli\u003eSurgery – Adjuvant RT.pdf\u003c\/li\u003e\n\u003cli\u003eSystemic therapies for metastatic Merkel cell carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eSystemic therapies for metastatic Merkel cell carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eTranscriptional Responses to Type II Interferon Treatment in Merkel cell carcinoma.mp4\u003c\/li\u003e\n\u003cli\u003eTranscriptional Responses to Type II Interferon Treatment in Merkel cell carcinoma.pdf\u003c\/li\u003e\n\u003cli\u003eUpdate on Australian MCC Clinical Trials.mp4\u003c\/li\u003e\n\u003cli\u003eUpdate on Australian MCC Clinical Trials.pdf\u003c\/li\u003e\n\u003cli\u003eWelcome Remarks \u0026amp; Course Intro.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954435330146,"sku":"MED-AMB03443","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UW-Medicine-2nd-International-Symposium-on-Merkel-Cell-Carcinoma-2022-1.png?v=1779376638","url":"https:\/\/meducourse.com\/products\/uw-medicine-2nd-international-symposium-on-merkel","provider":"Meducourse","version":"1.0","type":"link"}